OCRL Antikörper (N-Term)
-
- Target Alle OCRL Antikörper anzeigen
- OCRL (Oculocerebrorenal Syndrome of Lowe (OCRL))
-
Bindungsspezifität
- N-Term
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser OCRL Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA, Immunohistochemistry (IHC)
- Spezifität
- Reacts with human 104 kDa OCRL protein
- Kreuzreaktivität
- Maus
- Kreuzreaktivität (Details)
- Cross reacts with proteins from mouse and other species.
- Aufreinigung
- Purified (protein A)
- Immunogen
- Synthetic peptide derived from Nter domain of human OCRL protein
- Top Product
- Discover our top product OCRL Primärantikörper
-
anti-Oculocerebrorenal Syndrome of Lowe (OCRL) (AA 146-239) antibody
OCRL Reaktivität: Human WB, ELISA, IHC (p), RNAi Wirt: Maus Monoclonal 4A6 unconjugated
anti-Oculocerebrorenal Syndrome of Lowe (OCRL) (C-Term) antibodyOCRL Reaktivität: Human WB, IHC (p), ICC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Oculocerebrorenal Syndrome of Lowe (OCRL) (AA 146-240) antibodyOCRL Reaktivität: Human WB, IHC (p), EIA Wirt: Maus Monoclonal 4A6 unconjugated
anti-Oculocerebrorenal Syndrome of Lowe (OCRL) (AA 121-271) antibodyOCRL Reaktivität: Human ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Oculocerebrorenal Syndrome of Lowe (OCRL) (AA 146-240) antibodyOCRL Reaktivität: Human WB, ELISA, IHC, IHC (p) Wirt: Maus Monoclonal 4A6 unconjugated
anti-Oculocerebrorenal Syndrome of Lowe (OCRL) (Internal Region) antibodyOCRL Reaktivität: Human, Maus WB, ELISA Wirt: Kaninchen Polyclonal unconjugated
anti-Oculocerebrorenal Syndrome of Lowe (OCRL) antibodyOCRL Reaktivität: Human, Maus, Ratte WB Wirt: Kaninchen Polyclonal unconjugated
anti-Oculocerebrorenal Syndrome of Lowe (OCRL) (AA 1-893) antibodyOCRL Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
anti-Oculocerebrorenal Syndrome of Lowe (OCRL) (AA 1-893) antibodyOCRL Reaktivität: Human WB Wirt: Maus Polyclonal unconjugated
anti-Oculocerebrorenal Syndrome of Lowe (OCRL) (C-Term) antibodyOCRL Reaktivität: Human, Maus WB, ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
-
Working dilution: Optimal dilution should be determined by the end user.
The following are guidelines only :
- IHC : 1/50 to 1/500 - WB : 1/500 to 1/2 000 - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Must be reconstituted in distilled water.
- Buffer
- Tris 0,1M, glycine 0,1M, sucrose 2 %
- Lagerung
- 4 °C/-20 °C
- Informationen zur Lagerung
- Lyophilized powder stable for a minimum of 2 years at -20°C. Store reconstituted antibodies at +4°C. For extended periods store in aliquots at -20°C. Antibodies are guaranteed for 6 month from date of receipt.
- Haltbarkeit
- 24 months
-
- Target
- OCRL (Oculocerebrorenal Syndrome of Lowe (OCRL))
- Andere Bezeichnung
- Inositol Polyphosphate 5-Phosphatase OCRL-1 (OCRL Produkte)
- Synonyme
- OCRL antikoerper, wu:fi09g03 antikoerper, zgc:152864 antikoerper, locr antikoerper, nphl2 antikoerper, ocrl1 antikoerper, inpp5f antikoerper, INPP5F antikoerper, LOCR antikoerper, NPHL2 antikoerper, OCRL-1 antikoerper, OCRL1 antikoerper, 9530014D17Rik antikoerper, BB143339 antikoerper, OCRL, inositol polyphosphate-5-phosphatase antikoerper, phosphatidylinositol polyphosphate 5-phosphatase antikoerper, oculocerebrorenal syndrome of Lowe antikoerper, Ocrl antikoerper, NAEGRDRAFT_58601 antikoerper, OCRL antikoerper, ocrl antikoerper
- Hintergrund
- Converts phosphatidylinositol 4,5-bisphosphate to phosphatidylinositol 4-phosphate. May function in lysosomal membrane trafficking by regulating the specific pool of phosphatidylinositol 4,5-bisphosphate that is associated with lysosomes. Involved in primary cilia assembly.
- UniProt
- Q01968
- Pathways
- Inositol Metabolic Process
-
